ASLAN Pharmaceuticals (ASLN) News Today $0.60 0.00 (0.00%) As of 09/2/2025 Add Compare Share Share Headlines Stock AnalysisChartCompetitorsOptions ChainSEC FilingsTrendsBuy This Stock ASLN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Public Health News | Today's Latest Stories | ReutersOctober 3, 2024 | reuters.comASLAN stock tumbles 54% after board votes to liquidateJuly 19, 2024 | msn.comWhy ASLAN Pharmaceuticals (ASLN) Shares Are Down 40%July 19, 2024 | msn.comWhy ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionJuly 19, 2024 | msn.comASLAN Pharmaceuticals Announces it Has Filed for Voluntary Liquidation of Its Sole Operating Subsidiary and is Commencing Steps to Place Itself Into Voluntary LiquidationJuly 17, 2024 | globenewswire.comASLAN Pharmaceuticals Announces Receipt of Nasdaq Delisting Determination; Has Determined Not to AppealJuly 15, 2024 | globenewswire.comASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the American Thoracic Society International ConferenceMay 21, 2024 | globenewswire.comASLAN Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 9, 2024 | globenewswire.comASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL EventMay 7, 2024 | globenewswire.comASLAN Pharmaceuticals Announces Expansion of its Collaboration With Zenyaku to Investigate the Biology Underlying Differential Effects of Eblasakimab Compared to Other BiologicsMay 2, 2024 | globenewswire.comASLAN Pharmaceuticals to Host KOL Panel Discussion on Treatment Options for Atopic Dermatitis Patients With an Inadequate Response to DupilumabApril 30, 2024 | globenewswire.comASLAN Pharmaceuticals Announces Late Breaking Abstract on Eblasakimab in COPD Accepted for Presentation at the American Thoracic Society International ConferenceApril 24, 2024 | finance.yahoo.comAslan Announces Positive Results For Phase 2 Study Of Eblasakimab In AD PatientsApril 22, 2024 | markets.businessinsider.comASLAN Pharmaceuticals Announces Positive Interim Results From Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis PatientsApril 22, 2024 | globenewswire.comASLAN PHARMACEUTICALS LIMITED: ASLAN Pharmaceuticals Announces Receipt of Nasdaq NoticeApril 20, 2024 | finanznachrichten.deASLAN Pharmaceuticals Announces Receipt of Nasdaq NoticeApril 19, 2024 | globenewswire.comASLAN PHARMACEUTICALS LIMITED: ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateApril 13, 2024 | finanznachrichten.deASLAN Falls On Q4 FiguresApril 12, 2024 | msn.comASLN Stock Earnings: ASLAN Pharma Misses EPS for Q4 2023April 12, 2024 | markets.businessinsider.comASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateApril 12, 2024 | globenewswire.comAslan Pharmaceuticals to Present at the 2nd Annual H.C. Wainwright Autoimmune and Inflammatory Disease Virtual Conference: Skin Diseases, Conditions and DisordersMarch 27, 2024 | globenewswire.comAnalysts Offer Insights on Healthcare Companies: Aslan Pharmaceuticals (ASLN), Urogen Pharma (URGN) and Legend Biotech (LEGN)March 18, 2024 | markets.businessinsider.comASLN Apr 2024 5.000 callMarch 18, 2024 | finance.yahoo.comWeek In Review: Under Pressure From U.S. Congress, WuXi AppTec Resigns From BIOMarch 17, 2024 | seekingalpha.comSmart Home Healthcare Market to Reach USD 160.7 Billion by 2032, at 24.3% CAGR: Astute AnalyticaMarch 14, 2024 | finance.yahoo.comREGN May 2024 885.000 callMarch 14, 2024 | finance.yahoo.comASLAN Pharmaceuticals announces $5M registered direct offeringMarch 12, 2024 | msn.comASLAN Pharmaceuticals (Nasdaq:ASLN) HeadlineTrading was temporarily halted for "ASLN" at 02:03 PM with a stated reason of "LULD pause."...March 12, 2024 | marketbeat.comASLAN Pharmaceuticals Announces $5 Million Registered Direct OfferingMarch 12, 2024 | globenewswire.comPiper 'confident' partner or buyer will see benefit of Aslan's eblasakimabMarch 12, 2024 | realmoney.thestreet.comU.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.12%March 11, 2024 | msn.comASLAN Pharmaceuticals (Nasdaq:ASLN) HeadlineTrading was temporarily halted for "ASLN" at 03:03 PM with a stated reason of "LULD pause." Trading set to resume at 03:03 PM. March 11, 2024 | marketbeat.comASLAN Pharmaceuticals (Nasdaq:ASLN) HeadlineTrading was temporarily halted for "ASLN" at 03:03 PM with a stated reason of "LULD pause."...March 11, 2024 | marketbeat.comASLAN Pharmaceuticals (Nasdaq:ASLN) HeadlineTrading was temporarily halted for "ASLN" at 03:03 PM with a stated reason of "LULD pause." Trading set to resume at 03:03 PM. March 11, 2024 | marketbeat.comASLAN Pharmaceuticals (Nasdaq:ASLN) HeadlineTrading was temporarily halted for "ASLN" at 02:03 PM with a stated reason of "LULD pause."...March 11, 2024 | marketbeat.comASLAN Pharmaceuticals (Nasdaq:ASLN) HeadlineTrading was temporarily halted for "ASLN" at 02:03 PM with a stated reason of "LULD pause."...March 11, 2024 | marketbeat.comASLAN Pharmaceuticals (Nasdaq:ASLN) HeadlineTrading was temporarily halted for "ASLN" at 02:03 PM with a stated reason of "LULD pause."...March 11, 2024 | marketbeat.comBank Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Lower in Monday TradingMarch 11, 2024 | msn.comASLAN Pharmaceuticals Announces New Translational Data on Eblasakimab in COPD and Appoints Leading Respiratory Experts as Scientific AdvisorsMarch 6, 2024 | finance.yahoo.comAsian Equities Traded in US as ADRs Edge Higher Monday AfternoonMarch 4, 2024 | msn.comTech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Higher in Thursday TradingFebruary 29, 2024 | msn.comASLAN Pharmaceuticals Receives Favorable Opinion From the European Patent Office on Composition of Matter Patent Application for FarudodstatFebruary 29, 2024 | globenewswire.comBank, Auto Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Sharply Lower WednesdayFebruary 28, 2024 | msn.comAsian Equities Traded in the US as American Depositary Receipts Rise in Tuesday TradingFebruary 27, 2024 | msn.comASLAN Pharmaceuticals Limited (ASLN)February 20, 2024 | finance.yahoo.comASLAN Pharmaceuticals Ltd ADRFebruary 20, 2024 | morningstar.comMAslan Pharmaceuticals Ltd. ADRFebruary 17, 2024 | wsj.comTechnology Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Modestly Higher in Thursday TradingDecember 14, 2023 | msn.comASLAN PHARMACEUTICALS LIMITED: ASLAN Pharmaceuticals Provides Year-End Update on Its Eblasakimab and Farudodstat ProgramsDecember 12, 2023 | finanznachrichten.deASLAN Pharmaceuticals Provides Year-End Update on Its Eblasakimab and Farudodstat ProgramsDecember 12, 2023 | finance.yahoo.com Get ASLAN Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ASLN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ASLN Media Mentions By Week ASLN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ASLN News Sentiment▼0.000.70▲Average Medical News Sentiment ASLN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ASLN Articles This Week▼00▲ASLN Articles Average Week Get the Latest News and Ratings for ASLN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for ASLAN Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ONCO News CDT News CPHI News OGEN News REVB News GLTO News INM News SPRB News EVAX News TCRT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ASLN) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ASLAN Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share ASLAN Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
